Measuring heart and lung function after going to high altitudes
Official title: Measurement of Cardiopulmonary Variables in a Large Group of Healthy Subjects with Acute Exposure to High Altitude
Run by Centro Cardiologico Monzino · NCT05769140 · Data updated 2026-11-12
This study is trying to see how high altitudes affect heart and lung function in people, especially those with existing heart problems, by observing their responses in a cable car setting.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 8000 (estimated) |
| Sponsor | Centro Cardiologico Monzino Academic / other |
| Locations | 1 site (Courmayeur, Aosta) |
| Status | Recruiting |
| Started | March 25, 2020 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | September 4, 2024 |
| Trial ID | NCT05769140 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 years and older, particularly those with cardiovascular conditions or those planning to visit high-altitude locations.
✕Probably not a fit
Patients under 18 years of age will not benefit from this study as they are excluded from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the cardiovascular and respiratory responses of individuals exposed to high altitudes, where oxygen availability is reduced. It focuses on understanding how the body compensates for decreased oxygen levels, particularly in individuals with pre-existing cardiovascular conditions. The study seeks to gather data on the physiological changes that occur at high altitudes, which is currently limited in existing literature. By utilizing modern cable cars, the study will include a diverse group of participants, including sedentary and elderly individuals.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the cardiovascular risks associated with high altitude exposure, potentially guiding preventive measures for vulnerable populations.
How similar studies have gone: While there is limited data on cardiovascular responses at high altitudes, this study aims to fill a gap in the literature, suggesting that it may be a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years Exclusion Criteria: * Age \< 18 years
Where it's running
-
Skyway Monte Bianco
Courmayeur, Aosta, Italy Recruiting
Study contacts
- Principal investigator: Piergiuseppe Agostoni, Prof — Centro Cardiologico Monzino
- Study coordinator: Piergiuseppe Agostoni, Prof
- Email: piergiuseppe.agostoni@ccfm.it
- Phone: +39 0258002772
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How altitude affects outcomes for children with acute respiratory distress
This project will see if higher altitude and differences in hospital critical-care resources change outcomes for children (1 month–18 years) with PARDS who need invasive mechanical ventilation.
-
Acetazolamide and plasma volume changes at high altitude
This study will see if acetazolamide helps prevent early plasma volume loss and related altitude symptoms in healthy adults who normally live at low altitude.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Automated Echocardiography Measurements Using Deep-Learning Software
This study tests whether US2.AI can automatically measure heart structure and function from standard echocardiograms as accurately as expert clinicians in adults.
-
Insights from the FAST-TRACK CABG Experience in Complex Multivessel Disease
This study tests whether imaging-derived markers from CCTA and FFRCT can predict symptom relief and major cardiovascular outcomes after CCTA-guided CABG in people with complex multivessel disease.
-
What happens to the tricuspid valve in atrial fibrillation patients without strong valve leakage
This study looks at how the tricuspid valve changes over a year in people with atrial fibrillation who don’t have significant valve leakage, using 3D heart imaging.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.